{"disease":{"id":"relapsed-and-refractory-cd5-hematological-tumors","name":"relapsed and refractory cd5 hematological tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07234110","title":"CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}